CD27 Molecule (CD27) (C-Term) Peptide
Quick Overview for CD27 Molecule (CD27) (C-Term) Peptide (ABIN8096522)
Target
Origin
Source
Application
-
-
Protein Region
- C-Term
-
Purpose
- CD27 Peptide - C-terminal region
-
Sequence
- LHQRRKYRSN KGESPVEPAE PCRYSCPREE EGSTIPIQED YRKPEPACSP
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Comment
-
This is a synthetic peptide designed for use in combination with anti-CD27 Antibody(ARP59093_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- CD27 (CD27 Molecule (CD27))
-
Background
-
Background Information: The protein encoded by this gene is a member of the TNF-receptor superfamily. This receptor is required for generation and long-term maintenance of T cell immunity. It binds to ligand CD70, and plays a key role in regulating B-cell activation and immunoglobulin synthesis. This receptor transduces signals that lead to the activation of NF-kappaB and MAPK8/JNK. Adaptor proteins TRAF2 and TRAF5 have been shown to mediate the signaling process of this receptor. CD27-binding protein (SIVA), a proapoptotic protein, can bind to this receptor and is thought to play an important role in the apoptosis induced by this receptor.
Alternative Symbols: MGC20393, S152, T14, TNFRSF7, Tp55
-
Molecular Weight
- 27kDa
-
Gene ID
- 939
-
NCBI Accession
- NP_001233
-
UniProt
- P26842
Target
-